These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [New hot start technology in the polymerase chain reaction]. Rybalkin IN; Mukhamedova NM; Vlasik TN; Chenchik AA Biull Eksp Biol Med; 1996 Feb; 121(2):238-40. PubMed ID: 9026140 [No Abstract] [Full Text] [Related]
27. The implications of using mutagenic primers in combination with Taq polymerase having proofreading activity. Papadopoulou E; Metaxa-Mariatou V; Hatzaki A; Hatzis T; Nasioulas G Biologicals; 2004 Jun; 32(2):84-7. PubMed ID: 15454186 [TBL] [Abstract][Full Text] [Related]
28. Random mutagenesis of gene-sized DNA molecules by use of PCR with Taq DNA polymerase. Zhou YH; Zhang XP; Ebright RH Nucleic Acids Res; 1991 Nov; 19(21):6052. PubMed ID: 1658751 [No Abstract] [Full Text] [Related]
29. Exonuclease activity of proofreading DNA polymerases is at the origin of artifacts in molecular profiling studies. Gury J; Zinger L; Gielly L; Taberlet P; Geremia RA Electrophoresis; 2008 Jun; 29(11):2437-44. PubMed ID: 18429330 [TBL] [Abstract][Full Text] [Related]
30. Pitfalls of in situ polymerase chain reaction (PCR) using direct incorporation of labelled nucleotides. Sällström JF; Zehbe I; Alemi M; Wilander E Anticancer Res; 1993; 13(4):1153. PubMed ID: 8394673 [TBL] [Abstract][Full Text] [Related]
31. Fidelity of DNA polymerases for PCR. Hengen PN Trends Biochem Sci; 1995 Aug; 20(8):324-5. PubMed ID: 7667892 [No Abstract] [Full Text] [Related]
33. [Molecular biology in malignant blood diseases. Methodological aspects: Southern blotting techniques and the polymerase chain reaction]. González M; García Sanz R; Chillon MC; Balanzategui A; Vargas M; García MF; San Miguel JF Sangre (Barc); 1996 Aug; 41(4):311-9. PubMed ID: 8984673 [No Abstract] [Full Text] [Related]
34. Residual DNA in thermostable DNA polymerases - a cause of irritation in diagnostic PCR and microarray assays. Ehricht R; Hotzel H; Sachse K; Slickers P Biologicals; 2007 Apr; 35(2):145-7. PubMed ID: 16905333 [TBL] [Abstract][Full Text] [Related]
35. Application of the C4'-alkylated deoxyribose primer system (CAPS) in allele-specific real-time PCR for increased selectivity in discrimination of single nucleotide sequence variants. Tews B; Wilhelm J; Summerer D; Strerath M; Marx A; Friedhoff P; Pingoud A; Hahn M Biol Chem; 2003; 384(10-11):1533-41. PubMed ID: 14669997 [TBL] [Abstract][Full Text] [Related]
36. Removal of contaminating TEM-la beta-lactamase gene from commercial Taq DNA polymerase. Song JS; Lee JH; Lee JH; Jeong BC; Lee WK; Lee SH J Microbiol; 2006 Feb; 44(1):126-8. PubMed ID: 16554728 [TBL] [Abstract][Full Text] [Related]
37. [Water-soluble eumelanin as a PCR-inhibitor and a simple method for its removal]. Yoshii T; Tamura K; Taniguchi T; Akiyama K; Ishiyama I Nihon Hoigaku Zasshi; 1993 Aug; 47(4):323-9. PubMed ID: 8377274 [TBL] [Abstract][Full Text] [Related]
38. Patent on PCR enzymes may re-ignite old controversy. Dickson D Nature; 1994 Nov; 372(6503):212. PubMed ID: 7969459 [No Abstract] [Full Text] [Related]
39. PCR based diagnosis in the presence of 8% (v/v) blood. Panaccio M; Lew A Nucleic Acids Res; 1991 Mar; 19(5):1151. PubMed ID: 1845305 [No Abstract] [Full Text] [Related]